Xiong-ying D. Jiang
107 Yanjiang West Road
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Hepatic Artery Infusion Chemotherapy for Cholangiocarcinoma in 2025.
Journal: Liver cancer
Published: October 08, 2025
Hepatocellular carcinoma surveillance: a health economic evaluation.
Journal: Clinical and molecular hepatology
Published: September 19, 2025
Reply to correspondence on "Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography".
Journal: Clinical and molecular hepatology
Published: September 11, 2025
Immunotherapy versus lenvatinib in hepatocellular carcinoma: the need for granular data and prospective validation.
Journal: Journal for immunotherapy of cancer
Published: July 19, 2025
In-depth analysis of AFP trajectories in HCC: bridging gaps in survival data and clinical applicability.
Journal: International journal of surgery (London, England)
Published: June 30, 2025
Advancing VR therapy research: strengthening health economic analysis in postoperative pain management.
Journal: International journal of surgery (London, England)
Published: June 28, 2025
A Metrology Informatics Investigation of Conversion Therapy in Hepatocellular Carcinoma: 2014-2023.
Journal: Annals of surgery open : perspectives of surgical history, education, and clinical approaches
Published: October 23, 2024
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis.
Journal: Journal of gastrointestinal oncology
Published: July 19, 2024
Additional Hepatic Arterial Infusion Chemotherapy to Sorafenib Was Cost-Effective for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis.
Journal: Journal of hepatocellular carcinoma
Published: April 20, 2024
Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness Evaluation.
Journal: The American journal of gastroenterology
Published: November 20, 2023
Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: Multicenter, real-world study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: October 17, 2023
Cost-effectiveness and prognostic model of hepatic arterial infusion chemotherapy for hepatocellular carcinoma with high tumor burden and/or Vp4 tumor thrombus compared with sorafenib: a post-hoc analysis of the FOHAIC-1 trial.
Journal: International journal of surgery (London, England)
Published: May 25, 2023
Last Updated: 09/26/2026